ReviewCurrent gene therapy2026

Targeting of YKL-40 as a Protumor in Personalized Medicine: A New Dimension in Disease Understanding.

Hebatallah Ahmed Mohamed Moustafa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.